Ebola medical therapy

Overview
Treatment is primarily supportive and includes: Convalescent Plasma (factors from those who have survived Ebola infection) shows promise as a treatment for the disease. Ribavirin is ineffective. Interferon is also thought to be ineffective. In monkeys, administration of an inhibitor of coagulation (rNAPc2) has shown some benefit, protecting 33% of infected animals from a usually 100% (for monkeys) lethal infection (unfortunately this inoculation does not work on humans). In early 2006, scientists at USAMRIID announced a 75% recovery rate after infecting four rhesus monkeys with Ebola virus and administering antisense drugs.
 * Minimizing invasive procedures
 * Balancing electrolytes since patients are frequently dehydrated
 * Replacing lost coagulation factors to help stop bleeding
 * Maintaining oxygen and blood levels
 * Treating any complicating infections.